Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial.

MLA

Woltman, Andrea M., et al. “Alpha-Galactosylceramide in Chronic Hepatitis B Infection: Results from a Randomized Placebo-Controlled Phase I/II Trial.” Antiviral Therapy, vol. 14, no. 6, 2009, pp. 809–18. EBSCOhost, https://doi.org/10.3851/IMP1295.

APA

Woltman, A. M., Ter Borg, M. J., Binda, R. S., Sprengers, D., von Blomberg, B. M. E., Scheper, R. J., Hayashi, K., Nishi, N., Boonstra, A., van der Molen, R., & Janssen, H. L. A. (2009). Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial. Antiviral Therapy, 14(6), 809–818. https://doi.org/10.3851/IMP1295

Chicago

Woltman, Andrea M, Martijn J Ter Borg, Rekha S Binda, Dave Sprengers, B Mary E von Blomberg, Rik J Scheper, Kunihiko Hayashi, et al. 2009. “Alpha-Galactosylceramide in Chronic Hepatitis B Infection: Results from a Randomized Placebo-Controlled Phase I/II Trial.” Antiviral Therapy 14 (6): 809–18. doi:10.3851/IMP1295.